Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma on Thursday announced they have subscribed to partnership interest in healthcare services firm ABCD Technologies at a cost of Rs 40 crore each.
The four pharmaceutical companies will acquire 20% stake each in ABCD Technologies, which will be renamed as IndoHealth Services.The objective of acquisition is to facilitate, enable and promote efficiency and Good Distribution Practices including digitizing healthcare infrastructure in India, in support of the National Digital Health Mission of Government of India.
ABCD Technologies was incorporated on 10 February 2021. The entity is a newly incorporated limited liability partnership (LLP) and has not commenced any business activities.
Sun Pharmaceutical was down 0.28% at 575.8, shares of Lupin were trading 1.11% lower at Rs 980.8, Cadila Healthcare declined 0.27% to Rs 418.85 while Torrent Pharmaceuticals was up 0.19% at Rs 2449.45 on BSE.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app